Blog

Preferences

Privacy is important to us, so you have the option of disabling certain types of storage that may not be necessary for the basic functioning of the website. Blocking categories may impact your experience on the website. More information

Accept all cookies

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News & Updates...

When you're in the hot seat, having just delivered your biotech pitch deck, the Q&A session with venture capitalists (VCs) can feel like a rapid-fire round on a game show. But fear not! Understanding the typical questions VCs ask can turn this nerve-wracking experience into an opportunity to shine. So, let's dive into the world of biotech pitch decks and decode the minds of VCs.

In the realm of cybersecurity pitch decks, the number of slides is a crucial factor that can make or break the effectiveness of your presentation. Common wisdom suggests aiming for a sweet spot of 10-15 slides. This recommendation is not arbitrary; it's deeply rooted in the understanding of the viewer's attention span and the nature of dialogue in business settings.

The realm of cybersecurity is rapidly evolving (always, right? it seems it will never start declining). And with it, the need for compelling pitch decks that resonate with investors and stakeholders. Here, we dive into what makes these pitch decks not just informative but crucial in securing the right attention and investment.